Search Results - "Pélerin, Fanny"
-
1
Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
Published in Virulence (31-12-2018)“…In this study, we demonstrate, for the first time, that Saccharomyces cerevisiae-based probiotic shows an inhibitory effect on Gardnerella vaginalis infection…”
Get full text
Journal Article -
2
Probiotic Yeast Therapy for Irritable Bowel Syndrome
Published in Journal of neurogastroenterology and motility (30-07-2016)“…KCI Citation Count: 0…”
Get full text
Journal Article -
3
Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans
Published in Regulatory toxicology and pharmacology (01-02-2017)“…Bacillus subtilis CU1 is a recently described probiotic strain with beneficial effects on immune health in elderly subjects. The following work describes a…”
Get full text
Journal Article -
4
Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
Published in World journal of gastroenterology : WJG (14-01-2017)“…AIM To confirm previous conclusions on Saccharomyces cerevisiae(S. cerevisiae) CNCM I-3856 for irritable bowel syndrome(IBS) management.METHODS An individual…”
Get full text
Journal Article -
5
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
Published in Virulence (02-01-2017)“…Vulvovaginal candidiasis is the most prevalent vaginal infection worldwide and Candida albicans is its major agent. Vulvovaginal candidiasis is characterized…”
Get full text
Journal Article -
6
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
Published in United European gastroenterology journal (01-06-2016)“…Background Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pain and/or discomfort…”
Get full text
Journal Article -
7
A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome
Published in Digestive and liver disease (01-02-2015)“…Abstract Background We aimed to evaluate clinical symptoms in subjects with irritable bowel syndrome receiving Saccharomyces cerevisiae in a randomized…”
Get full text
Journal Article -
8
A double‐blind, randomized, controlled clinical study to evaluate the properties of Saccharomyces cerevisiae CNCM I‐ 3856 on Irritable Bowel Syndrome management
Published in The FASEB journal (01-04-2012)“…Abstract only Probiotics show beneficial properties in the management of Irritable Bowel Syndrome (IBS). Saccharomyces cerevisiae CNCM I‐3856 already…”
Get full text
Journal Article -
9